Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men

Annals of Human Genetics

Volumn 66, Issue 2, 2002, Pages 111-124

  Talmud, P J ^a   Hawe, E ^a   Robertson, K ^a   Miller, G J ^b   Miller, N E ^c   Humphries, S E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIFACTORIAL INHERITANCE; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

ALCOHOL DRINKING; ALLELES; APOLIPOPROTEIN A-I; BLOOD PRESSURE; BODY MASS INDEX; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY DISEASE; ENVIRONMENT; EPISTASIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCOPROTEINS; HUMANS; LIPASE; LIVER; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK FACTORS; SINGLE-BLIND METHOD; SMOKING; TRIGLYCERIDES;

EID: 0036521102     PISSN: 00034800     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-1809.2002.00105.x     Document Type: Article

References (46)

1. Abbott, R. D., Wilson, P. W., Kannel, W.B. & Castelli, W.P. (1988). High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 8, 207-211.
2. Allayee, H., Aouizerat, B. E., Cantor, R. M., Dallinga Thie, G. M., Krauss, R. M., Lanning, C. D., Rotter, J. I., Lusis, A. J. & de Bruin, T. W. (1998). Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. Am. J. Hum. Genet. 63, 577-585.
3. Assmann, G. & Schulte, H. (1992). Relation of high-density lipoprotein cholesterol and TGs to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am. J. Cardiol. 70, 733-737.
4. Botma, G., Verhoeven, A. J. & Jansen, H. (2001). Hepatic lipase promoter activity is reduced by the C-480G and G-216A substitutions present in the common LIPC variant and is increased by Upstream Stimulatory Factor. Atherosclerosis 154, 625-632.
5. Bu, X., Warden, C. H., Xia, Y. R., De Meester, C., Puppione, D. L., Teruya, S., Lokensgard, B., Daneshmand, S., Brown, J. & Gray, R. J. (1994). Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum. Genet. 93, 639-648.
6. Castro, G., Nihoul, L. P., Dengremont, C., de Geitere, C., Delfly, B., Tailleux, A., Fievet, C., Duverger, N., Denefle, P., Fruchart, J. C. & Rubin, E. M. (1997). Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport. Biochemistry 36, 2243-2249.
7. Chakravarti, A., Buetow, K. H., Antonarakis, S. E., Waber, P. G., Boehm, C. D. & Kazazian, H. H. (1984). Nonuniform recombination within the human beta-globin gene cluster. AJHG 36, 1239-1258.
8. Corbex, M., Poirier, O., Fumeron, F., Betoulle, D., Evans, A., Ruidavets, J. B., Arveiler, D., Luc, G., Tiret, L. & Cambien, F. (2000). Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction. Genet. Epidemiol. 19, 64-80.
9. Craig, W. Y., Palomaki, G. E., Johnson, A. M. & Haddow, J. E. (1990). Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis. Pediatrics 85, 155-158.
10. Day, I. N. M. & Humphries, S. E. (1994). Electrophoresis for genotyping: Microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal. Biochem. 222, 389-395.
11. Dullaart, R. P., Hoogenberg, K., Dikkeschei, B. D. & van Tol, A. (1994). Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler. Thromb. 14, 1581-1585.
12. Eliasson, B., Mero, N., Taskinen, M. R. & Smith, U. (1997). The insulin resistance syndrome and post-prandial lipid intolerance in smokers. Atherosclerosis 129, 79-88.
13. Fisher, R. M., Humphries, S. E. & Talmud, P. J. (1997). Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135, 145-159.
14. Freeman, D. J., Packard, C. J., Shepherd, J. & Gaffney, D. (1990). Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin. Sci. Colch. 79, 575-581.
15. Freeman, D. J., Griffin, B. A., Murray, E., Lindsay, G. M., Gaffney, D., Packard, C. J. & Shepherd, J. (1993). Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur. J. Clin. Invest. 23, 630-640.
16. Freeman, D. J., Griffin, B. A., Holmes, A. P., Lindsay, G. M., Gaffney, D., Packard, C. J. & Shepherd, J. (1994). Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqIB RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb. 14, 336-344.
17. Freeman, D. J. & Packard, C. J. (1995). Smoking and plasma lipoprotein metabolism. Clin. Sci. 89, 333-342.
18. Freeman, D. J., Caslake, M. J., Griffin, B. A., Hinnie, J., Tan, C. E., Watson, T. D., Packard, C. J. & Shepherd, J. (1998). The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin: cholesterol acyl transferase activities in human plasma. Eur. J. Clin. Invest. 28, 584-591.
19. Fumeron, F., Betoulle, D., Luc, G., Behague, I., Ricard, S., Poirier, O., Jemaa, R., Evans, A., Arveiler, D. & Marques Vidal, P. et al. (1995). Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 96, 1664-1671.
20. Gudnason, V., Kakko, S., Nicaud, V., Savolainen, M. J., Kesaniemi, Y. A., Tahvanainen, E. & Humphries, S. (1999). Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur. J. Clin. Invest. 29, 116-128.
21. Guerra, R., Wang, J., Grundy, S. M. & Cohen, J. C. (1997). A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. U.S.A. 94, 4532-4537.
22. Hannuksela, M., Marcel, Y. L., Kesaniemi, Y. A. & Savolainen, M. J. (1992). Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J. Lipid Res. 33, 737-744.
23. Humphries, S. E., Nicaud, V., Margalef, J., Tiret, L. & Talmud, P. J. (1998). Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler. Thromb. Vasc. Biol. 18, 526-534.
24. Humphries, S. E., Peacock, R. & Gudnason, V. (1999). Genetic determinants of hyperlipidaemia. In Lipoproteins in Health and Disease (eds. J. Betteridge, R. Illingworth & J. Shepherd). Ballières, Ch. 8, pp. 127-162.
25. Jansen, H., Hop, W., van Tol, A., Bruschke, A. V. & Birkenhager, J. C. (1994). Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis 107, 45-54.
26. Jansen, H., Chu, G., Ehnholm, C., Dallongeville, J., Nicaud, V. & Talmud, P. J. (1999). The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler. Thromb. Vasc. Biol. 19, 303-308.
27. Kuivenhoven, J. A., Jukema, J. W., Zwinderman, A. H., de Knijff, P., McPherson, R., Bruschke, A. V., Lie, K. I. & Kastelein, J. J. (1998). The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N. Engl. J. Med. 338, 86-93.
28. Mann, C. J., Yen, F. T., Grant, A. M. & Bihain, B. E. (1991). Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J. Clin. Invest. 88, 2059-2066.
29. Martin, L. J., Connelly, P. W., Nancoo, D., Wood, N., Zhang, Z. J., Maguire, G., Quinet, E., Tall, A. R., Marcel, Y. L. & McPherson, R. (1993). Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J. Lipid Res. 34, 437-446.
30. McPherson, R., Grundy, S. M., Guerra, R. & Cohen, J. C. (1996). Allelic variation in the gene encoding the cholesteryl ester transfer protein is associated with variation in the plasma concentrations of cholesteryl ester transfer protein. J. Lipid Res. 37, 1743-1748.
31. Medical Research Council's Committee on Research into Chronic Bronchitis and Questionnaire on respiratory symptoms (1976).
32. Miller, S. A., Dykes, D. D. and Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215-1215.
33. Miller, G. J., Bauer, K. A., Barzegar, S., Foley, A. J., Mitchell, J. P., Cooper, J. A. & Rosenberg, R. D. (1995). The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men. Thromb. Haemost. 73, 82-86.
34. Miller, G. J., Bauer, K. A., Barzegar, S., Cooper, J. A. & Rosenberg, R. D. (1996). Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease. Thromb. Haemost. 75, 767-771.
35. Musliner, T. A. & Krauss, R. M. (1988). Lipoprotein subspecies and risk of coronary disease. Clin. Chem. 34, B78-B83.
36. Nanjee, M. N., Cooke, C. J., Wong, J. S., Hamilton, R. L., Olszewski, W. L. & Miller, N. E. (2001). Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins. Quantification of cholesterol uptake by hdl in tissue fluids. J. Lipid Res. 42, 639-648.
37. Ordovas, J. M., Cupples, L. A., Corella, D., Otvos, J. D., Osgood, D., Martinez, A., Lahoz, C., Coltell, O., Wilson, P. W. & Schaefer, E. J. (2000). Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: The Framingham study. Arterioscler. Thromb. Vasc. Biol. 20, 1323-1329.
38. Prineas, R. J., Crow, R. S. & Blackburn, H. (1982). The Minnesota Code Manual of Electrocardiographic Findings: standards and procedures for measurement and classification. John Wright, Boston.
39. Rader, D. J. & Maugeais, C. (2000). Genes influencing HDL metabolism: new perspectives and implications for atherosclerosis prevention. Mol. Med. Today 6, 170-175.
40. Rainwater, D. L., Blangero, J., Hixson, J. E., Birnbaum, S., Mott, G. E. & VandeBerg, J. L. (1992). A DNA polymorphism for LCAT is associated with altered LCAT activity and high density lipoprotein size distributions in baboons. Arterioscler. Thromb. 12, 682-690.
41. Steinmetz, J., Boerwinkle, E., Gueguen, R., Visvikis, S., Henny, J. & Siest, G. (1992). Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis 92, 219-227.
42. Stocks, J., Cooke, C. J. & Miller, N. E. (2000). A common lecithin: cholesterol acyltransferase gene variant (Ser208-Thr) [letter]. Atherosclerosis 149, 219-220.
43. Talmud, P. J., Edwards, K. L., Turner, C. M., Newman, B., Palmen, J. M., Humphries, S. E. & Austin, M. A. (2000). Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size: use of a novel tetranucleotide repeat within the CETP promoter. Circulation 101, 2461-2466.
44. Tato, F., Vega, G. L. & Grundy, S. M. (1997). Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler. Thromb. Vasc. Biol. 17, 56-63.
45. Wilson, P. W., Abbott, R. D., Castelli, W. P., Kannel, W. B., Garrison, R. J., Kalousdian, S., Bostom, A. G., Cupples, L. A., Jenner, J. L., Ordovas, J. M., Seman, L. J. & Schaefer, E. J. (1996). High density lipoprotein cholesterol and mortality. Arteriosclerosis 276, 544-548.
46. Wittrup, H. H., Tybjaerg Hansen, A. & Nordestgaard, B. G. (1999). Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99, 2901-2907.